Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Rachel Totaram"'
Autor:
Olivia K. Golan, Fatema Z. Ahmed, Barbara Andraka-Christou, Rachel Totaram, Yara Asi, Danielle Atkins
Publikováno v:
Health & Justice, Vol 12, Iss 1, Pp 1-11 (2024)
Abstract Background To promote parent-child reunification, family dependency drug courts (FDDCs) facilitate substance use disorder treatment for people whose children have been removed due to parental substance use. The COVID-19 pandemic disrupted FD
Externí odkaz:
https://doaj.org/article/939a5beb45ff453b95b6fb387f521524
Autor:
Barbara Andraka-Christou, Olivia Golan, Rachel Totaram, Maggie Ohama, Brendan Saloner, Adam J. Gordon, Bradley D. Stein
Publikováno v:
Annals of Medicine, Vol 55, Iss 1, Pp 514-520 (2023)
AbstractResearch objective Medications for opioid use disorder (MOUDs) – including methadone, buprenorphine, and naltrexone – are the most effective treatments for opioid use disorder (OUD). Historically, insurers have required prior authorizatio
Externí odkaz:
https://doaj.org/article/73ab7a9fa6254149989df06cb11455cc
Autor:
Barbara Andraka-Christou, Danielle N. Atkins, Morgan C. Shields, Olivia K. Golan, Rachel Totaram, Kendall Cortelyou, Glenn W. Lambie, Olena Mazurenko
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 18, Iss 1, Pp 1-10 (2023)
Abstract Background While person-centered care (PCC) includes multiple domains, residential substance use disorder (SUD) treatment clients may value certain domains over others. We sought to identify the PCC domains most valued by former residential
Externí odkaz:
https://doaj.org/article/d83d736743bf420bad0858347c273dd4
Autor:
Fatema Z. Ahmed, Barbara Andraka-Christou, M.H. Clark, Rachel Totaram, Danielle N. Atkins, Brandon del Pozo
Publikováno v:
Health & Justice, Vol 10, Iss 1, Pp 1-13 (2022)
Abstract Background Medications for opioid use disorder (MOUD) significantly decrease mortality but courts rarely refer participants with opioid use disorder to MOUD providers. Previous qualitative work suggests routine court referrals to MOUD provid
Externí odkaz:
https://doaj.org/article/63282265441346559f8912a6505ec17e
Autor:
Barbara Andraka-Christou, Olivia Randall-Kosich, Matthew Golan, Rachel Totaram, Brendan Saloner, Adam J. Gordon, Bradley D. Stein
Publikováno v:
Health & Justice, Vol 10, Iss 1, Pp 1-9 (2022)
Abstract Background Problem-solving courts have the potential to help reduce harms associated with the opioid crisis. However, problem-solving courts vary in their policies toward medications for opioid use disorder (MOUD), with some courts discourag
Externí odkaz:
https://doaj.org/article/6d8743ff94da45ee9ed99d5d8c8faffe
Autor:
Olivia K. Golan, Rachel Totaram, Fatema Z. Ahmed, Sarah Akil, Nafees Fatima-Hashani, Daniel Whitaker, Therese Pigott, Barbara Teresa Andraka-Christou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fcfd155dd6614f9789cd4d83e0a85a5
https://doi.org/10.2139/ssrn.4352154
https://doi.org/10.2139/ssrn.4352154
Publikováno v:
Substance Abuse. 43:415-424
Background: 12-step groups are the most common approach to managing opioid use disorder (OUD) in the U.S. Medications for OUD (MOUD) are the most effective tool for preventing opioid misuse and relapse. Previous research has identified stigma of MOUD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dc2a22188b106da45d862b12b79c93d
https://doi.org/10.1080/08897077.2021.1944957
https://doi.org/10.1080/08897077.2021.1944957
Autor:
Barbara Andraka-Christou, Brendan Saloner, Adam J. Gordon, Rachel Totaram, Olivia Randall-Kosich, Matthew Golan, Bradley D. Stein
Publikováno v:
The American journal of drug and alcohol abuse. 48(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdd15366ff70b7da25df6b3fc0abfa19
https://pubmed.ncbi.nlm.nih.gov/35772010
https://pubmed.ncbi.nlm.nih.gov/35772010
Autor:
Barbara Andraka-Christou, Adam J. Gordon, Joanne Spetz, Rachel Totaram, Matthew Golan, Olivia Randall-Kosich, Jordan Harrison, Spencer Calder, Stefan G. Kertesz, Bradley D. Stein
Publikováno v:
J Subst Abuse Treat
BACKGROUND: Buprenorphine is a life-saving medication for people with opioid use disorder (OUD). U.S. federal law allows advanced practice clinicians (APCs), such as nurse practitioners (NPs) and physician assistants (PAs), to obtain a federal waiver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e4a63b20d8f083c73ad73a0df2e35e7
https://escholarship.org/uc/item/6w44b6k1
https://escholarship.org/uc/item/6w44b6k1
Publikováno v:
The American journal on addictionsREFERENCES. 31(6)
Methadone treatment (MT) for opioid use disorder is only available in opioid treatment programs (OTPs) in the United States, with retention predictive of positive health outcomes. OTP discharge reason information is needed to develop interventions fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::065079f3c3666324e635ee1790e70a4b
https://pubmed.ncbi.nlm.nih.gov/35996855
https://pubmed.ncbi.nlm.nih.gov/35996855